Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Comparative Gastric Tolerability of Lysine Acetylsalicylate and Conventional Aspirin in the Dog

  • 8 Accesses

  • 3 Citations


The gastric tolerability of low dose conventional aspirin (acetylsalicylic acid) was compared with that of lysine acetylsalicylate in the dog. A total of 14 dogs were allocated to aspirin 250mg (n = 2) or 500mg (n = 4) tablets, lysine acetylsalicylate powder (LAS) corresponding to 250mg aspirin (n = 2) or to 500mg aspirin (n = 4), and to plain vehicle (n = 2). Animals were sacrificed after general anaesthesia. Macro- and microscopic examinations of gastric and duodenal mucosae were performed 3 or 5 hours after single dose oral administration. No significant duodenal lesions were found. On the gastric mucosa, vascular changes (oedema and microhaemorrhages) and foveolar atrophy were observed with a similar frequency and intensity in all groups receiving aspirin or LAS. Mucosal erosions with coagulative necrosis occurred only in the aspirin groups. Thus, the gastrotoxicity of aspirin at relatively low doses is apparent with a standard aspirin formulation, but seems substantially less when using a highly soluble acetylsalicylate salt.

This is a preview of subscription content, log in to check access.


  1. Bernades P. La pathologie gastrique induite par les médicaments antiinflammatoires. Mise au point. Gastroenterologie Clinique et Biologique 5: 46–57, 1981

  2. Bretagne JF, Feuillu A, Gosselin M, Gastard J. Aspirine et toxicité gastroduodénale. Etude endoscopique en double insu des effets d’un placebo, de l’aspirine et de l’acétylsalicylate de lysine chez le sujet sain. Gastroenterologie Clinique et Biologique 8: 28–32, 1984

  3. Chaudhury TK, Jacobson ED. Prostaglandin cytoprotection of gastric mucosa. Gastroenterology 74: 59–63, 1978

  4. Cooke AR. Gastric damage by drugs and the role of the mucosal barrier. Australian and New Zealand Journal of Medicine 6: 26–29, 1976

  5. Davenport HW. Salicylate damage to the gastric mucosal barrier. New England Journal of Medicine 276: 1307–1312, 1967

  6. Garner A, Felmström G, Heylings JR. Effects of antiinflammatory agents and prostaglandins on acid and bicarbonate secretions in the amphibian-isolated gastric mucosa. Gastroenterology 77: 451–457, 1979

  7. Journal Officiel des Communautés Européennes. Directives du conseil du 24 novembre 1986 (86/609/CEE)

  8. Journal Officiel Français. Arrêté du 19 avril 1988

  9. Kearon C, Hirsh J. Optimal dose for starting and maintaining low-dose aspirin. Archives of Internal Medicine 153: 700–702, 1993

  10. Pascal JP, Tournut R, Rumeau JL, Clanet J, Delpu J, et al. Incidence de la prise prolongée d’antiinflammatoires et d’antalgiques sur l’aspect histologique de la muqueuse gastrique. Etude comparative entre des sujets présentant un rhumatisme inflammatoire chronique et une population témoin. Gastroenterologie Clinique et Biologique 2: 15–22, 1978

  11. Pemberton RE, Strand LJ. A review of upper-gastrointestinal effects of the newer non steroidal antiinflammatory agents. Digestive Diseases and Sciences 24: 53–64, 1979

  12. Rees WD, Turnberg LA. Reappraisal of the effects of aspirin on the stomach. Lancet 2: 410–413, 1980

  13. Roderick PJ, Wilkes HC, Meade TW. The gastrointestinal toxicity of aspirin: an overview of randomized controlled trials. British Journal of Clinical Pharmacology 35: 219–226, 1993

Download references

Author information

Correspondence to Dr C. Trillou.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Trillou, C., Santoni, J.P. & Friedmann, J. Comparative Gastric Tolerability of Lysine Acetylsalicylate and Conventional Aspirin in the Dog. Drug Invest 7, 323–330 (1994). https://doi.org/10.1007/BF03258474

Download citation


  • Aspirin
  • Gastric Mucosa
  • Drug Invest
  • Coagulative Necrosis
  • Aspirin Group